3M Reaches $7.35 Billion Settlement for PFAS-Related Personal Injury Claims

3M's Landmark Settlement in PFAS Litigation

In a pivotal move for the company, 3M (NYSE: MMM) has announced a substantial settlement aimed at resolving a wide array of personal injury claims related to PFAS (per- and polyfluoroalkyl substances). This decision stems from the ongoing Aqueous Film-Forming Foam Multi-District Litigation (AFFF MDL), which has been a focal point in federal courts in South Carolina.

As part of the agreement, 3M commits a total of $7.35 billion, which possesses a present value of approximately $5.8 billion over the next nine years. This agreement is set to cover around 99% of all current personal injury claims linked with PFAS, which involve an estimated 115,000 to 120,000 plaintiffs. The settlement includes not only the claims from the AFFF MDL but also those outside of it.

Addressing the Claims

The settlement highlights 3M's efforts to manage both existing and future personal injury claims effectively. Specifically, the terms outline a payment structure where a $50 million payment is scheduled for 2026, while there will be no financial obligations in 2027. It's noteworthy that approximately 20% of payments are reserved for the final two years of this structured payout to align with 3M's obligations related to other legacy settlements.

In addition to the agreed payments, future claims will be handled through various mechanisms, including a $680 million reserve fund which is a part of the initial financial commitment. This reserve is intended to allocate funds for future plaintiff claims while encouraging participation in the resolution process.

3M's Perspective

William Brown, Chairman and CEO of 3M, expressed that this settlement marks a crucial milestone that significantly mitigates litigation uncertainty for the company. He pointed out that this agreement follows previous resolutions with both U.S. public water suppliers and the State of New Jersey regarding PFAS matters, showcasing the company's commitment to responsibly managing legacy issues.

3M has announced initiatives to phase out the use of PFAS compounds since 2000, and the company has undertaken additional steps by committing to ceasing all PFAS manufacturing globally by 2025. Historically, 3M has invested in modern water treatment technologies at facilities where PFAS products were made and continues to work on cleaning these sites.

This agreement, however, comes with a crucial note: it is not an admission of liability. The company cautions that if certain settlement conditions are unmet, it is prepared to continue defending itself in any ongoing litigation relating to PFAS.

Financial Implications

Financially, the settlement will necessitate a pre-tax charge of $5.8 billion in the last quarter of 2026. This adjustment will be categorized as a special item during the company's financial presentation, yet will not alter 3M's earlier 2026 financial projections. The nine-year payment plan allows 3M to maintain predictable cash flow while aligning with other corporate obligations.

3M remains well-positioned for managing both its short-term and long-term financial commitments due to its robust business model and proven cash flow capabilities.

Investor Engagement

To discuss the implications and details of this settlement, 3M will be holding an investor teleconference at 8:30 a.m. ET on November 4, 2026. Investors can access this discussion through the live webcast available on the 3M investor relations website.

This landmark resolution not only signifies a turning point for 3M in the realm of environmental accountability but also emphasizes the company's ongoing commitment to innovating and transforming industries through responsible practices. Learn more about how 3M is shaping its future by exploring updates on its website and news center.